Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Marjan Walli-Attaei(University of Oxford), Danielle M. Hari, Basil S. Lewis(Technion – Israel Institute of Technology), Clara K Chow(Westmead Hospital), Amparo Casanova, Rita Yusuf(Independent University), Salim Yusuf(Population Health Research Institute), Khalid Yusoff(Universiti Teknologi MARA), Martin McKee(London School of Hygiene & Tropical Medicine), Andrew Mente(McMaster University), Gregory D. Lewis(Brigham and Women's Hospital), Álvaro Reyes, Weiwei Hu(Dubai Health Authority), Viswanathan Mohan(Madras Diabetes Research Foundation), Iolanthé M. Kruger(North-West University), Scott A. Lear(Simon Fraser University), M Zhang(Population Health Research Institute), Koon Teo(Population Health Research Institute), Khalid F. AlHabib(King Saud University), Annika Rosengren(Sahlgrenska University Hospital), Ehimario Igumbor(University of the Western Cape), Philip Joseph(Population Health Research Institute), B Zhang(Wroclaw Medical University), Shofiqul Islam(Population Health Research Institute), Andrew Smyth(Ollscoil na Gaillimhe – University of Galway), Darryl P. Leong(Population Health Research Institute), Sumathy Rangarajan(McMaster University), D Agapay, Manmeet Kaur(Post Graduate Institute of Medical Education and Research), Gary Wong(Chinese University of Hong Kong), Chinthanie Ramasundarahettige(Health Sciences Centre), Afzalhussein Yusufali(Dubai Health Authority), Andrzej Szuba(Wroclaw Medical University), Álvaro Avezum(Sociedade de Nefrologia do Estado de São Paulo), Lovely Dayal(Population Health Research Institute), Martin O’Donnell(Ollscoil na Gaillimhe – University of Galway), Aytekin Oğuz(Istanbul Medeniyet University), Rasha Khatib(Birzeit University), Rajeev Gupta(Eternal Hospital), Gilles R. Dagenais(Institut universitaire de cardiologie et de pneumologie de Québec), Ahmed Zaki, Antonio Aliberti, Raman Kutty(University of Wrocław), Ahmad Bahonar(Isfahan University of Medical Sciences), Mahshid Dehghan(Population Health Research Institute), Fernando Laņas(Universidad de La Frontera)
Cited by 220
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet|2020|9.8k
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k